125 related articles for article (PubMed ID: 17157143)
1. Preventing recurrent vitreous hemorrhage.
Steel D; Habib M; Owen R
Ophthalmology; 2006 Dec; 113(12):2373-4; author reply 2374. PubMed ID: 17157143
[No Abstract] [Full Text] [Related]
2. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study.
Yeh PT; Yang CM; Yang CH; Huang JS
Ophthalmology; 2005 Dec; 112(12):2095-102. PubMed ID: 16225926
[TBL] [Abstract][Full Text] [Related]
3. Entry site treatment to prevent late recurrent postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Steel DH; Connor A; Habib MS; Owen R
Br J Ophthalmol; 2010 Sep; 94(9):1219-25. PubMed ID: 19955203
[TBL] [Abstract][Full Text] [Related]
4. Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial.
Entezari M; Ramezani A; Ahmadieh H; Bakhtiari P; Yaseri M; Soltani K
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):13-9. PubMed ID: 19779730
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
6. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography.
Steel DH; Habib MS; Park S; Hildreth AJ; Owen RI
Ophthalmology; 2008 Mar; 115(3):525-32. PubMed ID: 17976729
[TBL] [Abstract][Full Text] [Related]
7. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings.
Hershberger VS; Augsburger JJ; Hutchins RK; Raymond LA; Krug S
Ophthalmology; 2004 Jun; 111(6):1215-21. PubMed ID: 15177974
[TBL] [Abstract][Full Text] [Related]
8. [Results of a repeat vitrectomy in patients with recurrent hemorrhages into the vitreous body in diabetic retinopathy].
Glinchuk IaI; Deev LA; Iugaĭ AG; Khalil' A
Vestn Oftalmol; 1987; 103(3):23-6. PubMed ID: 2442875
[No Abstract] [Full Text] [Related]
9. [Efficiency of air tamponade in prevention of early recurrence of vitreal hemorrhage in diabetic patients with vitrectomy].
Brănişteanu D; Danielescu C; Irimia A; Robu M
Oftalmologia; 2006; 50(2):62-7. PubMed ID: 16927761
[TBL] [Abstract][Full Text] [Related]
10. [Post-vitrectomy hemorrhage in a diabetic patient: simple transconjunctivo-scleral puncture with injection of air].
Haut J; Larricart P; Abi-Rached J; Monin C; Van-Effenterre J
Bull Soc Ophtalmol Fr; 1986 May; 86(5):621-2. PubMed ID: 3829219
[No Abstract] [Full Text] [Related]
11. [Treatment of vitreous hemorrhages. Spontaneous hemorrhages].
Ruellan YM
Bull Soc Ophtalmol Fr; 1987 Nov; Spec No():41-48, 51-8, 61-8 passim. PubMed ID: 2448052
[No Abstract] [Full Text] [Related]
12. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic patients.
Cekic O; Batman C
Am J Ophthalmol; 1999 Jun; 127(6):740-1. PubMed ID: 10372896
[No Abstract] [Full Text] [Related]
13. Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy.
Cheema RA; Mushtaq J; Cheema MA
Int Ophthalmol; 2010 Apr; 30(2):137-42. PubMed ID: 19169862
[TBL] [Abstract][Full Text] [Related]
14. [Cryotherapy in hemorrhagic complications of diabetic retinopathy].
Szwarcowa C; Bogacki S; Philips R
Klin Oczna; 1988; 90(4-5):144. PubMed ID: 3241520
[No Abstract] [Full Text] [Related]
15. Diabetic retinopathy.
Harding S
Clin Evid; 2002 Jun; (7):580-8. PubMed ID: 12230684
[No Abstract] [Full Text] [Related]
16. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
17. Sclerotomy complications following pars plana vitrectomy.
Kreiger A
Br J Ophthalmol; 2001 Jan; 85(1):121-2. PubMed ID: 11133727
[No Abstract] [Full Text] [Related]
18. [Analysis of the Cochrane Review: Anti-vascular Endothelial Growth Factor for Prevention of Postoperative Vitreous Cavity Hemorrhage after Vitrectomy for Proliferative Diabetic Retinopathy. Cochrane Database Syst Rev. 2015;8:CD008214.].
Sousa DC; Leal I; Costa J; Vaz-Carneiro A
Acta Med Port; 2017 Aug; 30(7-8):513-516. PubMed ID: 28926323
[TBL] [Abstract][Full Text] [Related]
19. Causes and treatment of vitreous hemorrhage.
Goff MJ; McDonald HR; Johnson RN; Ai E; Jumper JM; Fu AD
Compr Ophthalmol Update; 2006; 7(3):97-111. PubMed ID: 16882398
[TBL] [Abstract][Full Text] [Related]
20. Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy.
Sawa H; Ikeda T; Matsumoto Y; Niiya A; Kinoshita S
Jpn J Ophthalmol; 2000; 44(2):154-60. PubMed ID: 10715383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
